Omnio AB is a biopharmaceutical company dedicated to revolutionizing the treatment of diabetic foot ulcers (DFUs) through the development of recombinant plasminogen therapeutics.
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
